Package 52536-487-37

Brand: verapamil hydrochloride

Generic: verapamil hydrochloride
NDC Package

Package Facts

Identity

Package NDC 52536-487-37
Digits Only 5253648737
Product NDC 52536-487
Product ID 52536-487_27ea8c5d-0f1f-0e1c-e063-6294a90a44e5
Description

100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (52536-487-37)

Marketing

Marketing Status
Marketed Since 2024-11-26
Brand verapamil hydrochloride
Generic verapamil hydrochloride
Sample Package No

Linked Drug Pages (1)

Verapamil Hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "27ea8c5d-0f1f-0e1c-e063-6294a90a44e5", "openfda": {"upc": ["0352536486378"], "unii": ["V3888OEY5R"], "rxcui": ["897584", "897590", "897596"], "spl_set_id": ["5f665d08-e1e4-422a-88c2-d8834abf9e1a"], "manufacturer_name": ["Wilshire Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (52536-487-37)", "package_ndc": "52536-487-37", "marketing_start_date": "20241126"}], "brand_name": "Verapamil Hydrochloride", "product_id": "52536-487_27ea8c5d-0f1f-0e1c-e063-6294a90a44e5", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "52536-487", "generic_name": "Verapamil Hydrochloride", "labeler_name": "Wilshire Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Verapamil Hydrochloride", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "NDA020943", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20241126", "listing_expiration_date": "20261231"}